These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4450861)

  • 1. [Immunological paralysis. VI. Split character of the immunological areactivity to the administration of high doses of Vi antigen].
    Levenson VI
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Nov; (11):67-72. PubMed ID: 4450861
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunological paralysis. V. The histological changes in the organs of mice following the administration of massive doses of typhoid Vi-antigen].
    Levenson VI; Durnova GN; Kaplanekiĭ AS
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Sep; (9):60-4. PubMed ID: 4440338
    [No Abstract]   [Full Text] [Related]  

  • 3. [Split immune tolerance of mice to S. typhi Vi antigen].
    Korukova AA; Filitis LN; Solov'ev VV
    Biull Eksp Biol Med; 1972 Oct; 73(10):54-7. PubMed ID: 4673785
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanisms of antigen-induced blockade of immune response and cyclophosphamide-promoted tolerance to Salmonella typhi Vi antigen.
    Prigozhina TB; Fontalin LN
    Eur J Immunol; 1980 Aug; 10(8):641-6. PubMed ID: 6156850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of macrophages in the development of an immune response to typhoid bacterial polysaccharide Vi-antigen].
    Vysokodvorova RI
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jun; 51(6):67-70. PubMed ID: 4471632
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunologic paralysis. II. Dynamics of spontaneous regeneration of immunologic reactivity in mice paralyzed with typhoid Vi-polysaccharide].
    Levenson VI
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Jun; 48(7):18-22. PubMed ID: 5571360
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative evaluation of the immunological activity of new typhoid vaccines with established prophylactic effectiveness (data from a controlled experiment)].
    Kovalevskaia IL; Shchelova ES; Ermolenko ZN; Braĭnina RA; Shandalov BIa
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Sep; 0(9):63-8. PubMed ID: 1239151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Protective properties of Vi-antigen preparations as dependent on their adhesin content].
    Alliluev AP; Kotel'nikova OV; Korneeva SA; Fish NG; Kulinich LI
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Dec; (12):21-6. PubMed ID: 2469269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genotypical characteristics of the immunological Vi-antibody maturation depending on the effect of Vi-antigen deposit in the body].
    Bunin KV; Firsanov VI; Kravtsov EG; Shchukin PI
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Sep; (9):49-53. PubMed ID: 596023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunologic paralysis. 3. Determination of antigens in mice paralysed with high doses of typhoid Vi-polysaccharides].
    Levenson VI
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Jun; 49(6):31-5. PubMed ID: 5071617
    [No Abstract]   [Full Text] [Related]  

  • 11. [Specific blockade of the immune response caused by an excessive dose of S. typhi Vi-antigen].
    Prigozhina TB
    Biull Eksp Biol Med; 1978 Apr; 85(4):444-7. PubMed ID: 566136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immune response and immune tolerance to the O-antigen of Shigella flexneri VI].
    Rubakova EI; Ermakov GP; Fontalin LN; Nesterenko VG; Belaia IuA
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jul; (7):77-80. PubMed ID: 2413664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunochemical properties of Vi antigen from Salmonella typhi Ty2: presence of two antigenic determinants.
    Szewczyk B; Taylor A
    Infect Immun; 1980 Aug; 29(2):539-44. PubMed ID: 6163712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Kinetics of rosette-forming cells in immunization of mice with Vi-antigens of typhoid bacilli].
    Pershin SB; Khalatian NA; Pinegin BV
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Jun; 49(6):14-7. PubMed ID: 4672315
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of hybrid strains of S, typhi and S. typhimurium for characterizing the biological activity of individual Salmonella antigens by the alternative recording of the experimental results].
    Levina LA; Zaĭdner IG
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Aug; (8):31-6. PubMed ID: 335742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Vi passive hemagglutination test in the sera of S. typhi carriers. I. Evaluation of 3 preparations of Vi antigen and O antigen].
    Blośnicka R
    Przegl Epidemiol; 1974; 28(4):447-52. PubMed ID: 4475446
    [No Abstract]   [Full Text] [Related]  

  • 17. [The immunotropic properties of fenazepam].
    Zabrodskiĭ PF
    Farmakol Toksikol; 1991; 54(2):59-61. PubMed ID: 1679399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on immunological paralysis. VI. Thymic-independence of tolerance and immunity to type 3 pneumococcal polysaccharide.
    Howard JG; Christie GH; Courtenay BM; Leuchars E; Davies AJ
    Cell Immunol; 1971 Dec; 2(6):614-26. PubMed ID: 4149977
    [No Abstract]   [Full Text] [Related]  

  • 19. [Inhibitory effect of Salmonella VI-antigen in serologic reactions based on active and passive hemagglutination].
    Basova NN; Pravdiuk EG; Biĭchaninova AA
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Apr; (4):103-5. PubMed ID: 7405450
    [No Abstract]   [Full Text] [Related]  

  • 20. Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi.
    Robbins JD; Robbins JB
    J Infect Dis; 1984 Sep; 150(3):436-49. PubMed ID: 6207249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.